Maynard Um
-
-
-
-
-
-
-
Verastem (VSTM) PT Lowered to $18 at BTIG
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Verastem (VSTM); "catalyst-rich 2026"
-
-
-
-
-
-
-
Verastem (VSTM) PT Raised to $14 at RBC Capital; 'Stock Is Oversold'
-
-
-
-
-
-
-
Verastem (VSTM) PT Lowered to $14 at Mizuho
-
-
-
-
-
-
-
Verastem Oncology (VSTM) announces publication of results from Phase 1 FRAME study
-
-
-
-
-
-
-
Verastem (VSTM) PT Raised to $19 at Jefferies
-
-
-
-
-
-
-
Verastem (VSTM) PT Raised to $10 at H.C. Wainwright
-
412,404 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

